2 completed, 1 active not recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Neoplasm of Lung: new trials by email Literature Review of Neoplasm of Lung trials Research Report on Neoplasm of Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of NanoPac Intratumoral Injection in Lung Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Lung Cancer, Nonsmall Cell, Lung Cancer | Phase 2 | Completed | NanOlogy, LLC | 18 | 2021-04-14 | 2025-05-23 |
| 9-ING-41 in Patients With Advanced Cancers 9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer | Phase 2 | Active not recruiting | Actuate Therapeutics Inc. | 350 | 2019-01-04 | 2026-04-03 |
| CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab APX005M, Nivolumab - Cancer, Non Small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | Completed | Apexigen America, Inc. | 140 | 2017-07-10 | 2023-12-26 |
Lung Neoplasms (3) · Neoplasms (2) · Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Glioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Kidney Neoplasms (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Sarcoma (1)
Lung Diseases (3) · Neoplasms by Site (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Bone Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1)
Paclitaxel (2) · 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · Albumin-Bound Paclitaxel (1) · Carboplatin (1) · Doxorubicin (1) · Gemcitabine (1) · Irinotecan (1) · Lomustine (1) · Nivolumab (1) · Powders (1) · Suspensions (1) · Taxes (1) · liposomal doxorubicin (1) · sotigalimab (1)
Actuate Therapeutics Inc. (1) · Apexigen America, Inc. (1) · NanOlogy, LLC (1)
United States (3) · Spain (2) · Belgium (1) · Canada (1) · France (1) · Netherlands (1) · Portugal (1)
PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 35815408, PMID 41981308